Spirovant Sciences achieves milestone for experimental cystic fibrosis treatment
The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...
STAT18h
The health care system is ill-equipped to recognize and treat cystic fibrosis in non-white patients
Rena Barrow has two sons with cystic fibrosis, born 20 years apart — but they faced the same terrible delay in diagnosis.
ReCode to secure funds for cystic fibrosis gene correction treatments
ReCode Therapeutics is set to secure up to $15m in additional funding from the Cystic Fibrosis Foundation to enhance its gene ...
westcentralonline16h
Saskatchewan expands access to life-changing cystic fibrosis drug
More cystic fibrosis (CF) patients in Saskatchewan now have access to Trikafta, a groundbreaking medication that improves ...
Leader-Post on MSN1d
Cystic fibrosis drug now available to more people in Saskatchewan
Cystic Fibrosis Canada (CFC) is celebrating the recommendation to expand coverage to patients with at least one of 152 rare ...
Spirovant Sciences doses first subject in cystic fibrosis gene therapy trial
"Spirovant Sciences doses first subject in cystic fibrosis gene therapy trial" was originally created and published by ...
Business Wire3d
ReCode Therapeutics Announces Additional Funding From the Cystic Fibrosis Foundation to Accelerate Development of Novel Gene Correction Therapeutics to Treat Cystic Fibrosis
About Cystic Fibrosis Cystic fibrosis (CF) is a progressive genetic disease that causes persistent lung infections and respiratory failure. CF is caused by mutations in the cystic fibrosis ...
Scientists announce progress toward ambitious atlas of human cells
Scientists unveiled on Wednesday the first blueprint of human skeletal development as they make progress toward the goal of ...
‘I am just so thankful’: The test that let little Mairead beat the odds
The findings of a landmark study bolster calls for the federal government to establish a free expanded carrier screening ...
pharmaphorum5d
Celebrations as NHS England agrees deal for Vertex’ cystic fibrosis triple
NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio ... including as many as 300 patients with rare mutations, which fall outside of the scope of EMA ...